Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Global Multiple Myeloma Epidemiology and Patient Flow Analysis - 2017

Posted on: 17 Nov 17
Global Multiple Myeloma Epidemiology and Patient Flow Analysis - 2017

PR Newswire

LONDON, Nov. 16, 2017

LONDON, Nov. 16, 2017 /PRNewswire/ -- Fore Pharma announced the results of its Multiple Myeloma patients study in a new report 'Global Multiple Myeloma Epidemiology and Patient Flow Analysis - 2017'.

Download the full report:

The report provides insights into Multiple Myeloma epidemiology, Multiple Myeloma diagnosed patients, and Multiple Myeloma treatment rate for top seven pharmaceutical markets. The study measures key indicators such as prevalence of Multiple Myeloma derived from epidemiological analysis, percentage of patients diagnosed with Multiple Myeloma, and percentage of patients treated with a therapy.

The study helps executives estimate Multiple Myeloma market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.

The report provides estimates and forecasts of Multiple Myeloma prevalence, Multiple Myeloma diagnosis rate, and Multiple Myeloma treatment rate for the period 2016 - 2025. The information is presented by leading geographies including the US, Germany, France, Spain, Italy, UK, and Japan. The study design is based on interpretation and analysis of data collected from physicians via primary interviews, registries, scientific journals, literatures, government databases and other secondary sources.

Key Features of the Report:
- Multiple Myeloma Patient Flow
- Multiple Myeloma Prevalence
- Multiple Myeloma Diagnosed Patients
- Multiple Myeloma Treated Patients

Download the full report:

About Reportbuyer
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers

For more information:
Sarah Smith
Research Advisor at
Tel: +44 208 816 85 48

View original content:

SOURCE ReportBuyer

PR Newswire

Last updated on: 17/11/2017

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.